CanaQuest Medical Corp Announces Filing of Cannabis/Botanical Provisional Patents
UNIQUE BOTANICAL AND TETRAHYDROCANNABINOL (“THC’) FORMULATION TREATING PSYCHIATRIC DISORDERS WITHOUT THE NEGATIVE PSYCHIATRIC SIDE-EFFECTS OF THC TORONTO, Feb. 05, 2019 -- CANAQUEST MEDICAL CORP (fka ALGAE DYNAMICS CORP) (OTC: “ADYNF”) (the "Company" or “CanaQuest”), a company developing unique health products and nutraceuticals utilizing cannabis and botanical oil extracts, has filed two provisional patents which stem from its sponsored research program at Western University in London, Ontario, Canada. The provisional patents cover the United States and Canada. The provisional patents cover a unique formulation utilizing the cannabis cannabinoid, THC, and a botanical extract to treat various psychiatric disorders, with the unique feature of elimination of the negative side effects associated with THC such as euphoria. [...]